Intratumoral Heterogeneity in a Patient With Metastatic Thymic Carcinoma on 18F-FDG, 68Ga-DOTATATE, and 68Ga-FAPI04 PET/CT.
Clin Nucl Med
; 47(1): e79-e80, 2022 Jan 01.
Article
in En
| MEDLINE
| ID: mdl-34392280
ABSTRACT
ABSTRACT Herein, we present a 72-year-old woman with metastatic thymic carcinoma, referred for salvage peptide receptor radionuclide therapy with 177Lu-DOTATATE after completing all treatment options according to current clinical practice and guidelines. However, the patient was not eligible for 177Lu-DOTATATE peptide receptor radionuclide therapy and underwent 68Ga-FAPI04 PET/CT to assess the potential for a FAP-targeted therapy.
Full text:
1
Database:
MEDLINE
Main subject:
Organometallic Compounds
/
Thymoma
/
Thymus Neoplasms
Type of study:
Guideline
Limits:
Aged
/
Female
/
Humans
Language:
En
Year:
2022
Type:
Article